Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis

CompletedOBSERVATIONAL
Enrollment

53

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

February 14, 2017

Study Completion Date

February 14, 2017

Conditions
Axial Spondyloarthritis
Interventions
DRUG

Treatment

Trial Locations (6)

2000

Frederiksberg Bispebjerg Hospitals, Dep. of Rheumatology, Copenhagen

2600

Glostrup Hospital, Dep. of Rheumatology, Copenhagen

2730

Herlev Hospital, Dep. of Radiology, Copenhagen

2900

Gentofte Hospital, Dep. of Rheumatology, Copenhagen

3400

Nordsjællands Hospital Hillerød, Dep. of Rheumatology, Hillerød

4600

Køge Hospital, Dep. of Rheumatology, Køge

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Professor Mikkel Østergaard

OTHER

NCT02011386 - Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis | Biotech Hunter | Biotech Hunter